 |
|
|
|
|
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Bicycle Therapeutics
| | | | | Year Established: | 2009 | | Main Contact: | Ros Deegan, MBA, President & CBO | | | | Other Contacts: | Alan Watt, Ph.D., MBA, Interim CSO
Michael Skynner, Ph.D., VP, Operations
Kevin Lee, Ph.D., MBA, CEO
Andrew Muncey, CFO
| | | | Company Description | | Bicycle Therapeutics is pioneering a new class of therapeutics to treat cancer and other debilitating diseases based on its proprietary bicyclic peptides (Bicycles®) platform. Bicycles® are a breakthrough new therapeutic class that combine antibody-like affinity and selectivity with small molecule-like tissue penetration, tuneable exposure and chemical synthesis. | |
|
|
|
|
|
|
|
